Loading...
Loading...
India's metformin imports from UNITED STATES total $1.6B across 525 shipments from 15 foreign suppliers. M S ASTRAZENECA PLP MOUNT VERNON leads with $1.1B in import value; the top 5 suppliers together control 99.8% of this origin. Leading Indian buyers include ASTRAZENECA PHARMA INDIA LIMITED. This corridor reflects India's pharmaceutical import demand for metformin — a diversified sourcing base with multiple active suppliers from UNITED STATES.

M S ASTRAZENECA PLP MOUNT VERNON is the leading Metformin supplier from UNITED STATES to India, with import value of $1.1B across 4 shipments. The top 5 suppliers — M S ASTRAZENECA PLP MOUNT VERNON, M/S. ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON, Raff & Hall Pharmacy, M S ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON, M/S. ASTRAZENECA PLP MOUNT VERNON — collectively account for 99.8% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | M S ASTRAZENECA PLP MOUNT VERNON | $1.1B | 4 | 72.7% |
| 2 | M/S. ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON | $413.7M | 14 | 26.3% |
| 3 | Raff & Hall Pharmacy | $7.4M | 6 | 0.5% |
| 4 | M S ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON | $5.4M | 1 | 0.3% |
| 5 | M/S. ASTRAZENECA PLP MOUNT VERNON | $784.6K | 6 | 0.0% |
| 6 | Good Health Pharma Supplies | $550.5K | 8 | 0.0% |
| 7 | ESPEE BIOPHARMA & FINECHEM LLC | $354.3K | 78 | 0.0% |
| 8 | M/S. ASTRAZENECA PLP MOUNT VERNON | $289.0K | 1 | 0.0% |
| 9 | M/S. ASTRAZENECA PHARMACEUTICALS PLP MOUNT VERNON | $244.3K | 4 | 0.0% |
| 10 | RAFF & HALL PHARMACY | $138.1K | 15 | 0.0% |
| 11 | ESPEE BIOPHARMA & FINECHEM LLC. | $87.2K | 17 | 0.0% |
| 12 | Espee Biopharma & Finechem LLC | $86.8K | 18 | 0.0% |
| 13 | ESPEE BIOPHARMA FINECHEM LLC | $84.4K | 30 | 0.0% |
| 14 | GRANULES PHARMACEUTICALS INC | $77.1K | 32 | 0.0% |
| 15 | NEWLIFE MEDICALS (USA).INC. | $76.9K | 3 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ASTRAZENECA PHARMA INDIA LIMITED | $1.6B | 30 | 99.4% |
| 2 | MSN LABORATORIES PRIVATE LIMITED | $7.5M | 23 | 0.5% |
| 3 | HETERO LABS LIMITED | $603.3K | 30 | 0.0% |
| 4 | CIPLA LIMITED | $164.4K | 23 | 0.0% |
| 5 | GRANULES INDIA LIMITED | $114.4K | 41 | 0.0% |
| 6 | INVENTIA HEALTHCARE LIMITED | $92.7K | 13 | 0.0% |
| 7 | UMEDICA LABORATORIES PRIVATE LIMITED | $89.9K | 4 | 0.0% |
| 8 | COPMED PHARMACEUTICALS PRIVATE LIMITED | $69.7K | 7 | 0.0% |
| 9 | USV PRIVATE LIMITED | $65.2K | 18 | 0.0% |
| 10 | MANKIND PHARMA LIMITED | $55.5K | 14 | 0.0% |
| 11 | LUPIN LIMITED | $54.9K | 15 | 0.0% |
| 12 | WINDLAS BIOTECH LIMITED | $41.8K | 12 | 0.0% |
| 13 | EXEMED PHARMACEUTICALS | $36.9K | 12 | 0.0% |
| 14 | AKUMS DRUGS AND PHARMACEUTICALS LIMITED | $36.2K | 6 | 0.0% |
| 15 | ZYDUS HEALTHCARE LIMITED | $32.3K | 6 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Metformin suppliers from UNITED STATES to India include M S ASTRAZENECA PLP MOUNT VERNON, M/S. ASTRAZENECA PHARMACEUTICALS LP MOUNT VERNON, Raff & Hall Pharmacy. The leading supplier is M S ASTRAZENECA PLP MOUNT VERNON with import value of $1.1B USD across 4 shipments. India imported Metformin worth $1.6B USD from UNITED STATES in total across 525 shipments.
India imported Metformin worth $1.6B USD from UNITED STATES across 525 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Metformin sourced from UNITED STATES include ASTRAZENECA PHARMA INDIA LIMITED, MSN LABORATORIES PRIVATE LIMITED, HETERO LABS LIMITED. The largest buyer is ASTRAZENECA PHARMA INDIA LIMITED with $1.6B in imports across 30 shipments.
The total value of Metformin imports from UNITED STATES to India is $1.6B USD, across 525 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
525 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists